Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Safety and Efficacy of Fycompa in Adolescents With Epilepsy (FYC02T)
jRCT1080224672Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- May 2019
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of perampanel in Focal Onset Epilepsy, epilepsy and generalized tonic-clonic seizure (GTCS), sponsored by Eisai Co., Ltd. Started May 2019; status: completed.
02
Drugs
perampanel
03
Conditions
Focal Onset Epilepsyepilepsygeneralized tonic-clonic seizure (GTCS)
Beyond the preview
Go deeper on jRCT1080224672.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1080224672.